Form 4: Ovintiv COO Exercises SARs, Sells Shares

Ovintiv Inc.'s EVP & COO, Gregory Dean Givens, exercised Stock Appreciation Rights and subsequently sold the acquired common stock on December 4, 2025.

Summary

• Gregory Dean Givens, EVP & COO of Ovintiv Inc. (OVV), reported transactions on December 4, 2025.
• Givens exercised 17,826 Stock Appreciation Rights (SARs) at an exercise price of $22.95 per share.
• Concurrently, Givens disposed of 17,826 shares of Ovintiv Inc. common stock at a price of $42.32 per share.
• Following these transactions, Givens beneficially owns 205,867 shares of Ovintiv Inc. common stock directly.
• The Stock Appreciation Rights were exercisable from September 10, 2019, and are set to expire on September 10, 2026.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the exercise of Stock Appreciation Rights and the subsequent sale of common stock, likely under a pre-arranged 10b5-1 plan. This type of transaction is generally neutral in sentiment as it often relates to executive compensation and personal financial planning rather than a direct signal about the company's immediate prospects.

Positives

• The exercise of Stock Appreciation Rights indicates that the executive saw value in the company's stock price exceeding the exercise price.
• The transaction was made pursuant to a Rule 10b5-1 plan, suggesting a pre-arranged, non-discretionary transaction rather than a reaction to immediate market conditions.

Negatives

• The sale of 17,826 shares by a key executive could be interpreted as a reduction in direct ownership, although it is often part of a pre-planned strategy for diversification or tax purposes.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: Minor impact. A routine insider sale under a 10b5-1 plan is generally not a strong signal of management's view on future performance.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where an executive exercised Stock Appreciation Rights and sold the resulting shares. Such transactions, particularly when executed under a Rule 10b5-1 plan, are often pre-scheduled for diversification or tax planning purposes and do not typically signal a change in the company's fundamental outlook. Therefore, this filing alone does not warrant a change in investment recommendation; a 'hold' stance remains appropriate based solely on this disclosure.

Keywords

Ovintiv Inc., OVV, Insider Trading, Form 4, Stock Appreciation Rights, SARs, Executive Compensation, Gregory Dean Givens, Common Stock, Share Sale